Cite
MLA Citation
Madeleine Tilanus-Linthorst et al.. “FaMRIsc trial shows: MRI breast screening for women with ≥20% lifetime risk is also cost-effective in Europe.” European journal of surgical oncology, vol. 47, no. 2, 2021, pp. e19–. http://access.bl.uk/ark:/81055/vdc_100160119346.0x00003c